Demecan has become the first German company to receive a cultivation license for medical cannabis under the new Medical Cannabis Law (MedCanG). This license includes several different phenotypes that Demecan will now cultivate for the German market. With this license, Demecan can immediately increase its production capacity by an annual yield of 2 tons and fully utilize the existing production capacities at the "Cannabis Campus" in Ebersbach. This license allows Demecan to achieve an annual yield of approximately 2 tons, with no quantity limit specified.
This license is crucial to meet the growing demand for medical cannabis and marks a turning point in supply by shifting the focus from imports to more domestic production.
Dr. Adrian Fischer, physician and Managing Director responsible for cultivation, commented: "This license is a huge step forward for Demecan and the entire industry. We are proud to be the first German company to take this step and look forward to providing our high-quality cannabis strains soon. Our goal is to further increase production and thus improve supply security, as there are currently many shortages in patient care."
The company is also pleased to announce that it achieved strong revenue growth since April 2024. Dr. Philipp Goebel, Managing Director and responsible for sales, adds: "The significantly increased demand is reflected in our strong sales and shows that we are on the right track. The new cultivation permit not only allows us to meet the growing demand but also enables the sustainable development of our company."
Since its founding in 2017, Demecan has established itself as a pioneer in the German cannabis scene. As the only independent company in Germany covering the entire value chain for medical cannabis - from cultivation and processing to storage and delivery to pharmacies - Demecan has made a significant contribution to ensuring patients are supplied with high-quality cannabis products.
The legalization of cannabis on April 1, 2024, has also significantly boosted the market for medical cannabis, and Demecan's new cultivation license sends another positive signal for the industry. With the expansion of production in Germany, Demecan aims to offer consumers quality-tested products from strictly regulated production.
For more information:
Demecan
[email protected]
www.demecan.de
Sign up for our daily Newsletter and stay up to date with all the latest news!
Subscribe I am already a subscriber